What Vitrocell Systems does

VITROCELL Systems GmbH is a privately held German designer and manufacturer of advanced in vitro cell culture exposure systems, headquartered in Waldkirch and founded in 1997. The company specializes in Air-Liquid Interface (ALI) technology, which enables direct exposure of mammalian cell cultures and tissue to airborne substances — including gases, complex mixtures, nanoparticles, and fibers — under physiologically relevant conditions and as a validated alternative to animal testing.

Its product portfolio spans continuous-flow exposure modules (e.g., VITROCELL 6/48, 12/12 PLUS, 24/24), single-droplet systems (Cloud Alpha family), dry powder systems (PowderX), a dedicated skin-exposure line (Skin Module, Skin Max, Skin Aerosol Max, Cloud Skin, Autosampler), and a full range of supporting infrastructure: aerosol and gas generators, dynamic dilution systems, smoking machines for tobacco and next-generation nicotine products (VC 1, VC 1/7, VC 10, Shisha Device, Essentials Vape & Smoke), and dosimetry tools (QCM/sQCM, Photometer 2.5, CalorQuanti with NanoLockin, FTIR with Gasmet, TOF-MS with Photonion). The company leverages technology integrations with AlveoliX (organ-on-chip), NanoLockin (lock-in thermography), Photonion (TOF-MS), and Gasmet (FTIR) to broaden platform scope.

Vitrocell generates revenue through configured hardware sales, a usage-based V-PACE pay-per-use service, a V-CARE service and support subscription, and recurring cell-culture consumables (CellQART inserts). It sells primarily through enterprise field sales configured to customer specifications, supported by direct website inquiries and an active presence at scientific conferences including ESTIV, EUROTOX, LIVe, AIT, MPS World Summit, and Aerosols & Microbiology. The customer base spans academic and research institutions, pharmaceutical and biotech companies, regulatory agencies and government bodies, and — historically — tobacco/nicotine, chemical, and consumer goods manufacturers, positioning Vitrocell to benefit from the global regulatory shift toward non-animal alternative methods (NAMs).

Name

Vitrocell Systems

Legal name

VITROCELL Systems GmbH

Website

https://vitrocell.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

VITROCELL Systems GmbH is a German manufacturer of air-liquid interface in vitro exposure systems for inhalation toxicology and skin research, serving pharmaceutical, academic, regulatory, and consumer-product customers worldwide with configured modules and supporting dosimetry, smoking, and aerosol equipment.

Ownership category

akta.pro rank

Product category

In Vitro Exposure Systems (Laboratory Scientific Instruments)

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Apparatus & Furniture (3821)

akta.pro primary industry

Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)

akta.pro secondary industry

In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems) (HLAAAIAJ)

Keywords

• In vitro exposure systems
• Air-liquid interface systems
• Inhalation toxicology equipment
• Cell culture exposure modules
• Smoking machine testing

Headquarters

HQ city

Waldkirch

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. In Vitro Exposure Systems (Hardware): Sale of cell culture exposure systems including modules, exposure tops, dilution systems, smoking machines, and dosimetry tools. Configured to customer specifications with turnkey installations and international training.
2. V-PACE Pay-Per-Use: Pay-per-use model for exposure systems, providing flexible access to equipment without capital purchase.
3. V-CARE Service & Support: Service and support packages for exposure systems including maintenance, calibration, and technical assistance.
4. cellQART Cell Culture Inserts: Sale of cell culture inserts for advanced in vitro research.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Vitrocell Systems designs, manufactures, installs, and services advanced in vitro cell culture exposure systems that enable direct exposure of mammalian cells and tissue at the air-liquid interface (ALI) to airborne substances including gases, complex mixtures, nanoparticles, fibers, and tobacco aerosols. Its portfolio includes continuous flow exposure modules, single droplet (Cloud Alpha) systems, dry powder (PowderX) systems, skin exposure modules, a full line of smoking machines, aerosol/dust generators, dilution systems, and dosimetry tools, complemented by V-PACE pay-per-use and V-CARE service programs.

Product overview

VITROCELL Systems offers a comprehensive portfolio of advanced in vitro exposure systems for inhalation toxicology and skin testing research. The core product line centers on air-liquid interface (ALI) exposure modules that enable direct exposure of mammalian cell cultures to airborne substances including gases, complex mixtures, nanoparticles, and fibers. The portfolio includes multiple exposure system types: (1) Continuous Flow Systems (VITROCELL 6/48, 12/12 PLUS, 24/24) for long-term exposures; (2) Single Droplet Systems (Cloud Alpha, Cloud Alpha MAX, Cloud Alpha MOVE) for liquid aerosols with gravitational settling; (3) Dry Powder Systems (PowderX) for scarce materials; and (4) Skin Exposure Modules (Skin Module, Skin Max Module, Skin Aerosol Max, Cloud Skin). Supporting infrastructure includes smoking machines (VC 1, VC 1 S-TYPE, VC 1/7, VC 10, VC 10 S-TYPE, Essentials Vape & Smoke) for tobacco and e-cigarette research, aerosol generators (4-Jet BioAerosol, VAGF, VAGK, VRBG, Abrasive Dust), dilution systems, and dosimetry tools (QCM, Photometer 2.5, CalorQuanti, FTIR, TOF-MS). The company also offers V-PACE pay-per-use and V-CARE service programs. Founded over 20 years ago, VITROCELL serves as a global market leader with headquarters in Waldkirch, Germany.

Differentiator

Problem solved

Functional benefit

Brands

• VITROCELL Skin Module: Skin exposure modules as alternative to glass-made Franz cells
• VITROCELL Cloud Alpha
• VITROCELL PowderX
• VITROCELL CalorQuanti
• V-PACE
• V-CARE
• CellQART

Products and services

• VITROCELL Cloud Alpha Single Droplet Exposure System Single droplet sedimentation system for dose-controlled and spatially uniform deposition of liquid aerosols on cells at the air-liquid interface; supports Cloud Alpha, Cloud Alpha MAX, and Cloud Alpha MOVE variants for direct exposure of mammalian cells or tissue.
• VITROCELL PowderX Dry Powder Exposure System Dry powder exposure system for direct aerosolization of smallest quantities (1-100 mg) of dry powders without prior suspension preparation; designed for 12- or 24-well sized inserts.
• VITROCELL 12/12 PLUS Continuous Flow Exposure Module Compact exposure module for 12-well sized inserts (with 24-well adapter) featuring electronic heating, 4x3 layout for 3 dilutions plus sham control with 3 replicates each, and integrated dosimetry options for continuous flow exposure.
• VITROCELL 6/48 Climatic Chamber Exposure Module Module system for 6-well sized inserts enabling 7 dilutions with 6 inserts per dilution plus clean air control; includes electronic temperature control at 37°C so no additional incubator is required.
• VITROCELL 24/24 Continuous Flow Exposure Module Medium throughput continuous flow exposure module for 24-well sized inserts with dynamic double-jet dilution system enabling 6 dilutions with 4 replicates each, individually controlled flow rates, and integrated heating.
• VITROCELL Skin Exposure Modules (Skin Module, Skin Max Module, Skin Aerosol Max, Cloud Skin) Skin exposure modules that serve as an alternative to glass-made Franz cells, providing improved handling, higher throughputs, and automation options for skin penetration and aerosol-on-skin studies.
• VC 1 Smoking Machine Manual smoking machine for conventional and electronic cigarettes with high-tech features including linear motor drive, programmable parameters, and shortest distance design for in vitro experiments.
• VC 1 S-TYPE Smoking Machine Manual smoking machine for chemical characterization and in vitro experiments supporting ISO, Health Canada, and up to 300 ml puff volume, with up to 5 ports for e-cigarettes and NGP devices.
• VC 1/7 Smoking Machine Linear smoking machine with 7 individually programmable syringe drives for conventional and electronic cigarettes, with mode options for e-cigarettes, button-actuated products, and combustion cigarettes.
• VC 10 Smoking Robot Fully automated smoking robot for conventional and electronic cigarettes with linear motor drive, magazine for up to 20 cigarettes, and compliance with ISO and Health Canada standards.
• VC 10 S-TYPE Smoking Robot High-end smoking robot with platform concept and docking stations, magazine for 300 cigarettes, quick-lock holder system, heated smoke path, and automated leak detection for conventional cigarettes, e-cigarettes, and heated tobacco products.
• VITROCELL Shisha Testing Device Testing device for water pipe tobacco compliant with ISO 22486, operating with the VC 1 Smoking Machine and supporting puff volumes up to 600 ml with charcoal or electrical heating.
• Essentials Vape & Smoke Smoking Machine Entry-level manual single-port smoking machine for combustion and electronic cigarettes, featuring touch-screen controls, bell and square puff profiles, no compressed air required, and bundled with a cell culture exposure module.
• VITROCELL QCM 6 and sQCM 12 Microbalance Sensors Quartz Crystal Microbalance sensors for real-time deposited-dose monitoring at 10 nanogram/cm² resolution; sQCM 12 features tool-free service and a bayonet connection design.
• VITROCELL Photometer 2.5 Precision particle concentration photometer with USB-C connectivity, self-identification, factory adjustment eliminating harmonization needs, and GLP documentation compliance.
• VITROCELL CalorQuanti Optical Dosimetry Tool Innovative optical dosimetry tool co-developed with NanoLockin, using lock-in thermography for real-time, non-invasive particle deposition monitoring on living cells at the air-liquid interface.
• VITROCELL Photonion Full Gas Analysis (TOF-MS) Time-of-Flight Mass Spectrometer system with three ionization techniques (SPI, REMPI, EI) for on-line real-time chemical gas analysis, with detection limits down to ppb-ppt range.
• VITROCELL FTIR Gas Analysis System Puff-by-puff quantification system for key constituents of e-cigarette aerosol using a Gasmet FTIR analyser with 1-second measurement intervals and Calcmet PRO software.
• VITROCELL 4-Jet BioAerosol Generator Bioaerosol generator for liquids, proteins, bacteria, and microorganisms with minimal sample volume and low flow rates (0.4-4 L/min), using a peristaltic pump for precise dosing.
• VITROCELL VAGF Nebulizing Generator Nebulizing generator for liquids, suspensions, and solutions with defined particle size below 2 microns, using integrated cyclone technology.
• VITROCELL VAGK Nebulizing Generator Nebulizing generator for liquids, suspensions, and solutions with integrated aerosol drying capability before submission to exposure modules.
• VITROCELL VRBG Generator Nebulizing generator for continuous, reproducible generation of polydisperse solid aerosols from bulk powder material, handling particle sizes from less than 0.1 micron to 100 microns.
• VITROCELL Abrasive Dust Generator Generator for dust particles from grinding, cutting, or abrasive processes, producing aerosols from synthetic materials, metals, ceramics, and fiber-reinforced plastics.
• VITROCELL Dynamic Dilution Systems Dynamic dilution systems using unique double-jet systems for homogeneous mixing of test aerosol with air, enabling flexible dose/response relationships.
• cellQART Cell Culture Inserts Cell culture inserts for advanced in vitro research, sold through VITROCELL's services.
• V-PACE Pay-Per-Use Exposure Systems Pay-per-use exposure system service model giving customers flexible access to Vitrocell exposure equipment without capital purchase.
• V-CARE Service & Support Service and support program for VITROCELL exposure systems including maintenance, calibration, and technical assistance.

Quantifiable outcome

• Reduced reliance on animal testing through validated alternative methods
• +2 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Four partnerships are on record, tiered core.

• AlveoliXcoreTechnology or IntegrationCooperation partner for organ-on-chip solutions. Joint demonstrations at MPS World Summit 2026 and collaborative workshops on inhalation exposure methods for advanced cell systems and organ-on-chip solutions. Combined advanced aerosol exposure systems with AlveoliX AX12 breathing organ-on-chip platform.
• NanoLockincoreTechnology or IntegrationJoint development partner for CalorQuanti, an innovative lock-in thermography system for real-time particle deposition monitoring. NanoLockin developed the core technology integrated into VITROCELL exposure modules.
• IIVS (Institute for In Vitro Sciences)coreStrategic or Co-development PartnerJoint hands-on workshops on inhalation exposure methods for advanced cell systems and organ-on-chip solutions. IIVS organized workshops for US government participants focusing on advanced non-animal methods (NAMs) for inhalation research.
• PhotonioncoreTechnology or IntegrationIntegration of Photonion's time-of-flight mass spectrometry (TOF-MS) technology into VITROCELL modules for on-line real-time chemical gas analysis. Technology enables soft ionization techniques for complex gas mixture analysis.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Cultex Laboratories: German-headquartered specialist in air-liquid interface (ALI) in vitro exposure systems for inhalation toxicology research. The most direct competitor to VITROCELL, offering overlapping ALI exposure modules, aerosol generation, and customized inhalation test rigs to research, regulatory, and tobacco industry customers.
• Epithelix: Swiss developer of 3D human airway epithelial models (MucilAir, SmallAir) widely used at the air-liquid interface for inhalation toxicology and respiratory drug testing. Highly comparable to VITROCELL because its tissues are commonly deployed inside ALI exposure systems, making it both a partner-class and competitor-class peer in the same end-customer workflow.
• MatTek Life Sciences: US-based producer of 3D in vitro tissue models including EpiAirway, EpiDerm, and EpiOral used in ALI toxicology, inhalation, and skin exposure studies. Comparable to VITROCELL because its reconstructed tissues are a primary consumable inside ALI exposure hardware, positioning both companies in the same NAMs research workflow.
• EMKA Technologies (Scireq): French-Canadian maker of respiratory and cardiovascular research instrumentation, including the flexiVent lung mechanics system and inhaled exposure platforms. Comparable to VITROCELL because it sells adjacent inhalation research equipment to overlapping pharma, academic, and tobacco research customers.

Emerging players

• Emulate: US organ-on-chip platform company whose Liver-Chip and related products target advanced in vitro toxicology and drug safety applications. Relevant to VITROCELL because organ-on-chip is the next-generation workflow in which ALI exposure hardware (VITROCELL's domain) is integrated, and competitors could either partner with or disintermediate specialized exposure module vendors.
• CN Bio: UK organ-on-chip company offering PhysioMimix single- and multi-organ platforms for drug metabolism, toxicity, and disease modeling. Comparable to VITROCELL because both target the shift toward more physiologically relevant in vitro models for safety assessment, with potential convergence (or competition) at the ALI exposure hardware layer.
• TissUse: German multi-organ-chip company developing HUMIMIC chip platforms that combine multiple organ models for systemic toxicity and ADME studies. Comparable to VITROCELL because its Berlin-based location and NAMs focus overlap with VITROCELL's Waldkirch footprint and regulatory-driven customer base.

Broad incumbents

• Thermo Fisher Scientific: Global life sciences tools leader with broad portfolios in cell culture, lab instruments, inhalation toxicology services, and analytical instrumentation. Comparable to VITROCELL as a broad incumbent with overlapping customer base and potential to bundle or acquire specialized ALI exposure technology.
• Sartorius: German-headquartered global supplier of bioprocessing equipment, cell culture consumables, and laboratory instruments. Comparable to VITROCELL because it serves overlapping pharma/biotech customers with adjacent cell culture and bioprocess solutions, and as a German mid-cap could be a natural strategic acquirer of NAMs exposure technology.
• Lonza: Swiss-headquartered global leader in cell and gene therapy manufacturing services, cell culture products, and contract development/manufacturing. Comparable to VITROCELL because it sells cell culture inputs and offers bioscience solutions to the same pharma/regulatory customers adopting NAMs and advanced in vitro models.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCmWTXBsPTSTWW3Zk9Mq5Udg
• LinkedInlinkedin.com/company/vitrocell-systems-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vitrocell Systems